Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
(NASDAQ: ATRA) Delayed: 9.69 -0.02 (0.21%)
Previous Close $9.71    52 Week High $40.80 
Open $9.73    52 Week Low $12.45 
Day High $10.19    P/E N/A 
Day Low $9.60    EPS $0.00 
Volume 37,767